102 related articles for article (PubMed ID: 15301538)
1. Prion protein interaction with the C-terminal SH3 domain of Grb2 studied using NMR and optical spectroscopy.
Lysek DA; Wüthrich K
Biochemistry; 2004 Aug; 43(32):10393-9. PubMed ID: 15301538
[TBL] [Abstract][Full Text] [Related]
2. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
Liemann S; Glockshuber R
Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
[TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular analysis of Grb2 SH3 domain mutants: interaction with Sos and dynamin.
Vidal M; Goudreau N; Cornille F; Cussac D; Gincel E; Garbay C
J Mol Biol; 1999 Jul; 290(3):717-30. PubMed ID: 10395825
[TBL] [Abstract][Full Text] [Related]
4. Mapping of possible prion protein self-interaction domains using peptide arrays.
Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
[TBL] [Abstract][Full Text] [Related]
5. Electron paramagnetic resonance evidence for binding of Cu(2+) to the C-terminal domain of the murine prion protein.
Cereghetti GM; Schweiger A; Glockshuber R; Van Doorslaer S
Biophys J; 2001 Jul; 81(1):516-25. PubMed ID: 11423433
[TBL] [Abstract][Full Text] [Related]
6. Solution structure of Grb2 reveals extensive flexibility necessary for target recognition.
Yuzawa S; Yokochi M; Hatanaka H; Ogura K; Kataoka M; Miura K; Mandiyan V; Schlessinger J; Inagaki F
J Mol Biol; 2001 Feb; 306(3):527-37. PubMed ID: 11178911
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
McDonald CB; Seldeen KL; Deegan BJ; Farooq A
Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
[TBL] [Abstract][Full Text] [Related]
8. How to Grb2 a Gab.
Wöhrle FU; Daly RJ; Brummer T
Structure; 2009 Jun; 17(6):779-81. PubMed ID: 19523893
[TBL] [Abstract][Full Text] [Related]
9. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor.
Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD
Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246
[TBL] [Abstract][Full Text] [Related]
10. Micellar environments induce structuring of the N-terminal tail of the prion protein.
Renner C; Fiori S; Fiorino F; Landgraf D; Deluca D; Mentler M; Grantner K; Parak FG; Kretzschmar H; Moroder L
Biopolymers; 2004 Mar; 73(4):421-33. PubMed ID: 14991659
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the beta-dystroglycan-growth factor receptor 2 (Grb2) interaction.
Russo K; Di Stasio E; Macchia G; Rosa G; Brancaccio A; Petrucci TC
Biochem Biophys Res Commun; 2000 Jul; 274(1):93-8. PubMed ID: 10903901
[TBL] [Abstract][Full Text] [Related]
12. The small 11-kDa protein from B19 parvovirus binds growth factor receptor-binding protein 2 in vitro in a Src homology 3 domain/ligand-dependent manner.
Fan MM; Tamburic L; Shippam-Brett C; Zagrodney DB; Astell CR
Virology; 2001 Dec; 291(2):285-91. PubMed ID: 11878897
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the cellular prion (PrPC) and the 2P domain K+ channel TREK-1 protein.
Azzalin A; Ferrara V; Arias A; Cerri S; Avella D; Pisu MB; Nano R; Bernocchi G; Ferretti L; Comincini S
Biochem Biophys Res Commun; 2006 Jul; 346(1):108-15. PubMed ID: 16750514
[TBL] [Abstract][Full Text] [Related]
14. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
[TBL] [Abstract][Full Text] [Related]
15. Structural insight into the binding diversity between the human Nck2 SH3 domains and proline-rich proteins.
Liu J; Li M; Ran X; Fan JS; Song J
Biochemistry; 2006 Jun; 45(23):7171-84. PubMed ID: 16752908
[TBL] [Abstract][Full Text] [Related]
16. Peptide NMHRYPNQ of the cellular prion protein (PrP(C)) inhibits aggregation and is a potential key for understanding prion-prion interactions.
Rehders D; Claasen B; Redecke L; Buschke A; Reibe C; Jehmlich N; von Bergen M; Betzel C; Meyer B
J Mol Biol; 2009 Sep; 392(1):198-207. PubMed ID: 19607841
[TBL] [Abstract][Full Text] [Related]
17. Sprouty2 binds Grb2 at two different proline-rich regions, and the mechanism of ERK inhibition is independent of this interaction.
Martínez N; García-Domínguez CA; Domingo B; Oliva JL; Zarich N; Sánchez A; Gutiérrez-Eisman S; Llopis J; Rojas JM
Cell Signal; 2007 Nov; 19(11):2277-85. PubMed ID: 17689925
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the interaction between prion protein and nucleic acid.
Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
[TBL] [Abstract][Full Text] [Related]
19. Modelling of the complex between a 15-residue peptide from mSos2 and the N-terminal SH3 domain of Grb2 by molecular-dynamics simulation.
Calero S; Lago S; van Gunsteren WF; Daura X
Chem Biodivers; 2004 Mar; 1(3):505-19. PubMed ID: 17191865
[TBL] [Abstract][Full Text] [Related]
20. Cellular prion protein interaction with vitronectin supports axonal growth and is compensated by integrins.
Hajj GN; Lopes MH; Mercadante AF; Veiga SS; da Silveira RB; Santos TG; Ribeiro KC; Juliano MA; Jacchieri SG; Zanata SM; Martins VR
J Cell Sci; 2007 Jun; 120(Pt 11):1915-26. PubMed ID: 17504807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
